Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy

ConclusionsOverall, the relative positioning of tumor lesions significantly influences the prognosis of patients with DLBCL receiving CAR T cell therapy. The ideal scenario involves tumors with minimal dissemination and no aggregation.

https://onlinelibrary.wiley.com/doi/10.1002/cam4.6991?af=R

Source: Cancer Medicine - March 20, 2024 Category: Cancer & Oncology Authors: Xiuyong Dang, Ping Li, Aijun Shen, Yan Lu, Zeyv Zhu, Min Zhang, Wenbin Qian, Aibin Liang, Wenjun Zhang Tags: RESEARCH ARTICLE Source Type: research